Published in Acta Ophthalmol Suppl on January 01, 1985
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med (2005) 3.80
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia (2007) 3.07
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet (1983) 2.35
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia (1980) 1.71
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia (2008) 1.70
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem (1997) 1.67
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
Transport of glucose from blood to brain. Physiol Rev (1979) 1.62
Insulin pharmacokinetics. Diabetes Care (1984) 1.60
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia (1982) 1.54
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diabet Med (2005) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis. Acta Physiol (Oxf) (2007) 1.52
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
How common is low back pain in the Nordic population? Data from a recent study on a middle-aged general Danish population and four surveys previously conducted in the Nordic countries. Spine (Phila Pa 1976) (1996) 1.45
Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia (1991) 1.43
Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia (1992) 1.42
Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes. Diabetologia (2010) 1.41
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed) (1982) 1.40
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) (1993) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1990) 1.39
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.37
Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia (1986) 1.37
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Why has the search for causes of low back pain largely been nonconclusive? Spine (Phila Pa 1976) (1997) 1.31
Accurate superimposition of perimetry data onto fundus photographs. Acta Ophthalmol (Copenh) (1990) 1.29
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem (1999) 1.28
Increased urinary albumin-excretion rate in benign essential hypertension. Lancet (1974) 1.28
Fast glycosylation of haemoglobin. Lancet (1979) 1.28
The association between physical workload and low back pain clouded by the "healthy worker" effect: population-based cross-sectional and 5-year prospective questionnaire study. Spine (Phila Pa 1976) (2001) 1.26
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia (1986) 1.26
Comparability of venous and capillary glucose measurements in blood. Diabet Med (2003) 1.26
Variation in 125I-insulin absorption and blood glucose concentration. Diabetologia (1979) 1.26
Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia (1983) 1.25
Short stature and diabetic nephropathy. BMJ (1995) 1.24
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes (1985) 1.23
Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 1.23
Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia (2004) 1.22
The influence of stimulus size on perimetric detection of small scotomata. Graefes Arch Clin Exp Ophthalmol (1989) 1.21
Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J (1977) 1.20
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes (1995) 1.20
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20
Cotton-wool spots and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1991) 1.19
Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes (1990) 1.18
Letter: Diagonal ear-lobe crease in coronary heart disease. N Engl J Med (1975) 1.18
Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study. Diabetologia (2006) 1.16
Reduced sweating in adults with growth hormone deficiency. Lancet (1989) 1.16
Screening for Type 2 diabetes--should it be now? Diabet Med (2003) 1.14
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia (2007) 1.13
Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab (2002) 1.12
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism (1994) 1.12
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes (1983) 1.12
HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish county. Scand J Prim Health Care (2001) 1.11
Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes (1988) 1.11
Potassium transport of the frog retinal pigment epithelium: autoregulation of potassium activity in the subretinal space. J Physiol (1986) 1.11
A five-year longitudinal study of hearing in a Danish rural population aged 31-50 years. Br J Audiol (2000) 1.11
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction. Diabetologia (2009) 1.11
Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years. Int J Epidemiol (1997) 1.11